Maternal weight gain is key to controlling infant birth weight…. Infants born to mothers with pregestational diabetes are more likely to experience adverse outcomes, especially an increased birth weight. Previous studies have shown the importance of strict maternal glycemic control to prevent fetal hyperinsulinemia and accelerated growth. Excessive gestational …

  Gastric bypass surgery shows better outcomes for long-term weight loss, controlling type 2 diabetes, hypertension, and cholesterol level…. Puzziferri and colleagues conducted a clinical review of 29 studies (7,971 patients) looking at outcomes of gastric bypass, gastric band or sleeve gastrectomy on patients with BMI ≥35 at 1 year …

Adding an SGLT2 inhibitor to multiple daily doses of insulin improved glycemic control, benefited weight loss, lowered insulin doses, and no increase in hypoglycemia was seen…   Some patients with inadequately controlled type 2 diabetes still do not achieve glycemic control with multiple daily doses of insulin. Empagliflozin is a …

  Adherence to healthy lifestyle during pregnancy is associated with a lower risk of gestational diabetes…. In a prospective cohort study, researchers looked at data on 14,437 women who participated in the Nurses’ Health Study II. Data was collected from the years of 1989-2001. Participants were aged 24 to 44 …

  SGLT-2 inhibitor use in the management of glucose in type 2 diabetes could reduce blood pressure in patients with hypertension…. In a new study, researchers found that empagliflozin lowered blood pressure in patients with type 2 diabetes and hypertension. Hypertension affects about two-thirds of patients with diabetes. See more …

Black Americans on Medicare are three times more likely than other patients to lose a leg to amputation because of complications with diabetes and peripheral arterial disease…. Even low-risk black patients with diabetes and peripheral arterial disease faced a higher risk of amputation than most nonblack patients, according to a …

However, older diabetes patients have a more serious attitude towards their disease….

Pilot study shows that an SGLT-2 inhibitor doses of 5-mg and 10-mg were associated with significant reductions in blood glucose and total daily insulin dose…. Dapagliflozin is a member of the SGLT2 inhibitor class of diabetic medications indicated only for treatment of type 2 diabetes. Dapagliflozin helps reduce blood glucose …

There is some interesting research going on at the University of Missouri about high protein breakfasts that actually delivers a profound message for a reason to use the medication Cycloset. Researchers found that eating breakfast, particularly meals rich in protein, increases young adults’ levels of dopamine which may reduce food …

Typically when we diagnose a type 2 patient we start on the normal pathway of metformin and “diet and exercise” modifications. For many of our patients this regimen makes a significant improvement in their glucose levels and A1c values…. But for those patients who don’t improve, we are then forced …